Sowell Financial Services’s Akcea Therapeutics Inc AKCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-104
Closed -$2K 2952
2020
Q3
$2K Sell
104
-332
-76% -$4.71K ﹤0.01% 2306
2020
Q2
$6K Buy
+436
New +$6.73K ﹤0.01% 1874

Sowell Financial Services's AKCA Position: Q4 2020 in Review

Sowell Financial Services sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 104 shares — an estimated $2K sold.

Sowell Financial Services first reported a position in AKCA in Q2 2020 and held it in 2 quarters. The position peaked at $6K in Q2 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Sowell Financial Services reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Sowell Financial Services sold 104 Akcea Therapeutics Inc shares in Q4 2020, an estimated $2K.
  • Sowell Financial Services first reported a position in Akcea Therapeutics Inc in Q2 2020 and held it in 2 quarters.
  • Sowell Financial Services's Akcea Therapeutics Inc position peaked at $6K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Sowell Financial Services's 13F filing for Q4 2020, filed 13 Jan 2021.